— Know what they know.
Not Investment Advice

ZHYBF OTC

Zhong Yuan Bio-Technology Holdings Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -44.4%
$2.02
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Distribution · Tech Score Sell · Power 47 · $35.8M mcap · 3M float · 0.0039% daily turnover · Short 57% of daily vol

Balance Sheet Trends

Total Assets
$3M +38.9% ▲
5Y CAGR: +11.1%
Total Liabilities
$3M +29.8% ▲
5Y CAGR: +51.6%
Shareholders Equity
-$205K +41.0% ▲
Cash & Investments
$145K -47.7% ▼
5Y CAGR: -16.0%
Total Debt
$3M +28.7% ▲
5Y CAGR: +66.3%
Net Debt
$2M +40.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$61K$195K$101K$278K$145K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$61K$195K$101K$278K$145K
Net Receivables$330K$531K$518K$354K$1M
Inventory$225K$1M$57K$131K$30K
Other Current Assets$835K$0$1M$223K$312K
Total Current Assets$2M$2M$2M$1M$2M
Property, Plant & Equip.$304K$1M$731K$518K$580K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$562K$562K
Other Non-Current Assets$446K$0$39K$0$238K
Total Non-Current Assets$750K$1M$770K$1M$1M
Total Assets$2M$3M$3M$2M$3M
— Liabilities —
Accounts Payable$0$0$0$0$0
Short-Term Debt$460K$402K$462K$1M$2M
Deferred Revenue$0$85K$4K$110K$3K
Other Current Liabilities$0$52K$54K$0$0
Total Current Liabilities$629K$761K$836K$2M$2M
Long-Term Debt$0$261K$367K$0$325K
Other Non-Current Liab.$0$0$5K$0$0
Total Non-Current Liabilities$171K$1M$1M$596K$904K
Total Liabilities$800K$2M$2M$3M$3M
— Equity —
Common Stock$17K$17K$18K$18K$18K
Retained Earnings-$214K-$242K-$1M-$3M-$3M
Accumulated OCI$113K$162K$176K$97K$179K
Total Stockholders Equity$1M$2M$941K-$347K-$205K
Total Liabilities & Equity$2M$3M$3M$2M$3M
— Key Metrics —
Total Debt$724K$2M$2M$2M$3M
Net Debt$663K$2M$2M$2M$2M
Total Investments$0$0$0$562K$562K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms